Intelligent Bio Solutions Inc Ordinary Shares INBS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.29
- Day Range
- $2.11–2.31
- 52-Week Range
- $2.08–24.90
- Bid/Ask
- $2.15 / $2.30
- Shares Outstanding
- 2.39M
- Market Cap
- $5.26M
- Volume/Avg
- 131,422 / 108,065
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.60
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 55
- Website
- https://www.ibs.inc
Valuation
|
Metric
|
INBS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.51 |
Price/Sales | 0.60 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
INBS
|
|---|---|
Quick Ratio | 1.80 |
Current Ratio | 2.11 |
Interest Coverage | −246.92 |
Quick Ratio
INBS
Profitability
|
Metric
|
INBS
|
|---|---|
Return on Assets (Normalized) | −91.02% |
Return on Equity (Normalized) | −172.92% |
Return on Invested Capital (Normalized) | −147.52% |
Return on Assets
INBS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|??><mB | LOCK|W?B@ | $155B | |||
| Stryker Corp
SYK
| LOCK|!@s<n<$ | LOCK|j! | $121B | |||
| Medtronic PLC
MDT
| LOCK|N!WwdBC | LOCK|mj>@W | $103B | |||
| Boston Scientific Corp
BSX
| LOCK|rGhLr$ | LOCK|T?ns | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<Bfpc@w | LOCK|>G^?x | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|#R?F@VK | LOCK|!f | $29B | |||
| DexCom Inc
DXCM
| LOCK|#nd&$?$v | LOCK|R!zj | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Ck | LOCK|C& | $26B | |||
| Steris PLC
STE
| LOCK|XJ??lvc | LOCK|>$>@B | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|&B>Zv#K | LOCK|&J | $17B |
United States